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Background
Cardiopulmonary bypass during cardiac surgery leads to impaired microcirculatory
perfusion. We hypothesized that vascular leakage is an important contributor to
microcirculatory dysfunction. Imatinib, a tyrosine kinase inhibitor, has been shown
to reduce vascular leakage in septic mice. We investigated whether prevention of
vascular leakage using imatinib preserves microcirculatory perfusion and reduces
organ injury markers in a rat model of cardiopulmonary bypass.
Methods
Male Wistar rats underwent cardiopulmonary bypass after treatment with imatinib
or vehicle (n=8 per group). Cremaster muscle microcirculatory perfusion and
quadriceps microvascular oxygen saturation were measured using intravital
microscopy and reflectance spectroscopy. Evans Blue extravasation was
determined in separate experiments. Organ injury markers were determined in
plasma, intestine, kidney, and lungs.
Results
The onset of cardiopulmonary bypass decreased the number of perfused
microvessels by 40% in the control group [9.4 (8.6–10.6) to 5.7 (4.8–6.2) per
microscope field; P<0.001 vs baseline], whereas this reduction was not seen in the
imatinib group. In the control group, the number of perfused capillaries remained
low throughout the experiment, whilst perfusion remained normal after imatinib
administration. Microvascular oxygen saturation was less impaired after imatinib
treatment compared with controls. Imatinib reduced vascular leakage and
decreased fluid resuscitation compared with control [3 (3–6) vs 12 ml (7–16);
P=0.024]. Plasma neutrophil-gelatinase-associated-lipocalin concentrations were
reduced by imatinib.
Conclusions
Prevention of endothelial barrier dysfunction using imatinib preserved
microcirculatory perfusion and oxygenation during and after cardiopulmonary
bypass. Moreover, imatinib-induced protection of endothelial barrier integrity
reduced fluid-resuscitation requirements and attenuated renal and pulmonary
injury markers.
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